Table 5.
Comparison between patients and controls according to genotype as regards clinical data
| Genotype | Homotype A/A | Homotype G/G | Heterotype | X 2 | P-value | |||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |||
| Patients group | ||||||||
| Multifetal or single | 0.792 | 0.673 | ||||||
| Single Fetus | 0 | 0.0% | 4 | 44.4% | 9 | 45.0% | ||
| Multi-fetus | 1 | 100.0% | 5 | 55.6% | 11 | 55.0% | ||
| HDP | 1.986 | 0.371 | ||||||
| Normotensive | 0 | 0.0% | 2 | 22.2% | 9 | 45.0% | ||
| Hypertensive | 1 | 100.0% | 7 | 77.8% | 11 | 55.0% | ||
| Gestational DM | 0.982 | 0.612 | ||||||
| Absent | 0 | 0.0% | 4 | 44.4% | 10 | 50.0% | ||
| Present | 1 | 100.0% | 5 | 55.6% | 10 | 50.0% | ||
| Familial cardiomyopathy | 3.00 | 0.223 | ||||||
| Absent | 1 | 100.0% | 9 | 100.0% | 15 | 75.0% | ||
| Present | 0 | 0.0% | 0 | 0.0% | 5 | 25.0% | ||
| Peripartum stage | 5.455 | 0.065 | ||||||
| Prepartum | 0 | 0.0% | 0 | 0.0% | 8 | 40.0% | ||
| Postpartum | 1 | 100.0% | 9 | 100.0% | 12 | 60.0% | ||
| Control group | ||||||||
| Multifetal or single | 2.112 | 0.348 | ||||||
| Single Fetus | 7 | 100.0% | 9 | 69.2% | 22 | 55.0% | ||
| Multi-fetus | 0 | 0.0% | 4 | 30.8% | 18 | 45.0% | ||
| HDP | 8.571 | P1=1.00 P2=0.217 P3=0.044* |
||||||
| Normotensive | 7 | 100.0% | 13 | 100.0% | 19 | 47.5% | ||
| Hypertensive | 0 | 0.0% | 0 | 0.0% | 21 | 52.5% | ||
| Gestational DM | 5.510 | 0.064 | ||||||
| Absent | 7 | 100.0% | 13 | 100.0% | 22 | 55.0% | ||
| Present | 0 | 0.0% | 0 | 0.0% | 18 | 45.0% | ||
| Familial cardiomyopathy | 4.138 | 0.126 | ||||||
| Absent | 7 | 100.0% | 11 | 84.6% | 40 | 100.0% | ||
| Present | 0 | 0.0% | 2 | 15.4% | 0 | 0.0% | ||
| Peripartum stage | 4.554 | 0.103 | ||||||
| Prepartum | 4 | 57.1% | 3 | 23.1% | 12 | 30.0% | ||
| Postpartum | 3 | 42.9% | 10 | 76.9% | 28 | 70.0% | ||
P1: Homotype A/A VS Homotype G/G, P2: Homotype A/A VS Heterotype, P3: Homotype G/G VS Heterotype
*Significant P-value if ≤ 0.05, ** highly significant P-value if ≤ 0.001